Document Detail

Late Sodium Current Inhibition in Acquired and Inherited Ventricular (dys)function and Arrhythmias.
MedLine Citation:
PMID:  23292167     Owner:  NLM     Status:  Publisher    
The late sodium current has been increasingly recognized for its mechanistic role in various cardiovascular pathologies, including angina pectoris, myocardial ischemia, atrial fibrillation, heart failure and congenital long QT syndrome. Although relatively small in magnitude, the late sodium current (I(NaL)) represents a functionally relevant contributor to cardiomyocyte (electro)physiology. Many aspects of I(NaL) itself are as yet still unresolved, including its distribution and function in different cell types throughout the heart, and its regulation by sodium channel accessory proteins and intracellular signalling pathways. Its complexity is further increased by a close interrelationship with the peak sodium current and other ion currents, hindering the development of inhibitors with selective and specific properties. Thus, increased knowledge of the intricacies of the complex nature of I(NaL) during distinct cardiovascular conditions and its potential as a pharmacological target is essential. Here, we provide an overview of the functional and electrophysiological effects of late sodium current inhibition on the level of the ventricular myocyte, and its potential cardioprotective and anti-arrhythmic efficacy in the setting of acquired and inherited ventricular dysfunction and arrhythmias.
Carol Ann Remme; Arthur A M Wilde
Related Documents :
15819987 - Tissue doppler echocardiographic quantification. comparison to coronary angiography res...
18774007 - Comparison of myocardial tissue velocities measured by two-dimensional speckle tracking...
17021437 - Intraoperative assessment of diastolic function: utility of echocardiography.
16640707 - Pre- and postoperative quantitation of right ventricular tissue doppler velocities in i...
10573497 - Left ventricular function in adults with mild pulmonary insufficiency late after fallot...
24350287 - Prooxidant mechanisms in iron overload cardiomyopathy.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2013-1-6
Journal Detail:
Title:  Cardiovascular drugs and therapy / sponsored by the International Society of Cardiovascular Pharmacotherapy     Volume:  -     ISSN:  1573-7241     ISO Abbreviation:  Cardiovasc Drugs Ther     Publication Date:  2013 Jan 
Date Detail:
Created Date:  2013-1-7     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8712220     Medline TA:  Cardiovasc Drugs Ther     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Department of Clinical and Experimental Cardiology, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands,
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  A novel dual oxidase maturation factor 2 gene mutation for congenital hypothyroidism.
Next Document:  Marked decline in beta cell function during pregnancy leads to the development of glucose intoleranc...